Structure Therapeutics Inc. (GPCR) Insider Trading
Over the last 3 months, GPCR insiders made 0 open-market buys and 3 sales, a net purchase of $0 (SEC Form 4). Over the last 6 months, 130 institutions increased and 124 reduced their position (13F).
Insider Activity
Sentiment
50/100
Buys (3m)
0
Sells (3m)
3
Net (3m)
$0
Insider trades by month Buys Sells
Aug
Dec
Jan
Apr
Jun
Jul
Context3-month price -0.2%Institutions mixed (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 15, 2026 | Lin Xichenofficer: CHIEF SCIENTIFIC OFFICER | Sell | 1,600 | — |
| Jul 15, 2026 | Lin Xichenofficer: CHIEF SCIENTIFIC OFFICER | Option | 23,634 | $0.34 |
| Jul 15, 2026 | Lin Xichenofficer: CHIEF SCIENTIFIC OFFICER | Sell | 6,278 | — |
| Jun 29, 2026 | Lin Xichenofficer: CHIEF SCIENTIFIC OFFICER | Option | 23,634 | $0.34 |
| Jun 29, 2026 | Lin Xichenofficer: CHIEF SCIENTIFIC OFFICER | Sell | 7,878 | — |
| Jun 18, 2026 | Russell Angus C.director | Grant | 39,453 | $15.00 |
| Jun 18, 2026 | LOVE TED Wdirector | Grant | 39,453 | $15.00 |
| Jun 18, 2026 | Waldstreicher Joannedirector | Grant | 39,453 | $15.00 |
| Jun 18, 2026 | DOBMEIER ERICdirector | Grant | 39,453 | $15.00 |
| Jun 18, 2026 | TETLOW SHARONdirector | Grant | 39,453 | $15.00 |
| Jun 18, 2026 | WELCH DANIEL Gdirector | Grant | 39,453 | $15.00 |
| Apr 23, 2026 | Lang Matthewofficer: COO & GC | Grant | 184,614 | — |
| Apr 23, 2026 | Lang Matthewofficer: COO & GC | Grant | 223,776 | $18.08 |
| Apr 16, 2026 | FMR LLC10 percent owner, other: See Remark 1 | Sell | 1,367 | — |
| Apr 16, 2026 | FMR LLC10 percent owner, other: See Remark 1 | Sell | 16,085 | — |
| Mar 23, 2026 | Hall Ashleyofficer: Chief Development Officer | Grant | 59,073 | $16.82 |
| Mar 23, 2026 | Stevens Raymond Cdirector, officer: CHIEF EXECUTIVE OFFICER | Grant | 322,230 | $16.82 |
| Mar 23, 2026 | Stevens Raymond Cdirector, officer: CHIEF EXECUTIVE OFFICER | Grant | 260,217 | — |
| Mar 23, 2026 | Yoon Junofficer: CHIEF FINANCIAL OFFICER | Grant | 128,892 | $16.82 |
| Mar 23, 2026 | Yoon Junofficer: CHIEF FINANCIAL OFFICER | Grant | 104,085 | — |
| Mar 23, 2026 | Lin Xichenofficer: CHIEF SCIENTIFIC OFFICER | Grant | 53,703 | $16.82 |
| Mar 23, 2026 | Lin Xichenofficer: CHIEF SCIENTIFIC OFFICER | Grant | 43,368 | — |
| Mar 23, 2026 | Ma Yingliofficer: CHIEF TECHNOLOGY OFFICER | Grant | 40,278 | $16.82 |
| Mar 23, 2026 | Ma Yingliofficer: CHIEF TECHNOLOGY OFFICER | Grant | 32,526 | — |
| Mar 23, 2026 | Coll Crespo Blasofficer: CHIEF MEDICAL OFFICER | Grant | 93,984 | $16.82 |
| Mar 23, 2026 | Coll Crespo Blasofficer: CHIEF MEDICAL OFFICER | Grant | 75,897 | — |
| Mar 23, 2026 | Hall Ashleyofficer: Chief Development Officer | Grant | 47,706 | — |
| Mar 5, 2026 | Yoon Junofficer: CHIEF FINANCIAL OFFICER | Tax | 22,305 | $20.99 |
| Mar 5, 2026 | Hall Ashleyofficer: Chief Development Officer | Tax | 4,836 | $20.99 |
| Mar 5, 2026 | Hall Ashleyofficer: Chief Development Officer | Grant | 225 | — |
Source: GPCR SEC Form 4 filings, latest Jul 15, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their GPCR positions over the last 6 months (SEC Form 13F).
Increased
130
New positions
100
Reduced
124
Sold out
76
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 8.7M | Feb 17, 2026 |
| FMR LLC | Reduced | 8.4M | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 7.3M | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 7.1M | Feb 17, 2026 |
| AVORO CAPITAL ADVISORS LLC | Reduced | 6.6M | May 15, 2026 |
| AVORO CAPITAL ADVISORS LLC | Increased | 6.6M | Mar 16, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 5.4M | May 18, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 5.1M | Feb 17, 2026 |
| DEEP TRACK CAPITAL, LP | Increased | 4.3M | May 15, 2026 |
| DEEP TRACK CAPITAL, LP | Reduced | 4.1M | Feb 13, 2026 |
| BVF INC/IL | Increased | 3.5M | Feb 17, 2026 |
| BVF INC/IL | Reduced | 3.5M | May 15, 2026 |
| MORGAN STANLEY | Reduced | 2.3M | May 15, 2026 |
| MORGAN STANLEY | Increased | 2.1M | Feb 13, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 2.0M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.